Catalyst Wire Dossier Catalyst Wire Dossier

Alpha-1 Antitrypsin (AAT)

alpha-1 antitrypsin · CSL Behring
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alpha-1 Antitrypsin (AAT), covering 2025-08-29 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone [Phase 3]

See pricing